March 2 (Reuters) - TG Therapeutics Inc :
* TG THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS
* QTRLY LOSS PER SHARE $0.71
* Q4 EARNINGS PER SHARE VIEW $-0.58 -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* TG THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS
* QTRLY LOSS PER SHARE $0.71
* Q4 EARNINGS PER SHARE VIEW $-0.58 -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)